ADVI CEO Marc Samuels On FDA Commissioner Gottlieb’s Comments Related to CAR-T Label Change
A label change to allow for more outpatient use would allow for a “defined path which has fewer hurdles than the reimbursement path in the inpatient setting,” ADVI founder and CEO Marc Samuels said in an interview with the Pink Sheet.
[el-text]
Written by Cathy Kelly
***excerpt***
A label change to allow for more outpatient use would allow for a “defined path which has fewer hurdles than the reimbursement path in the inpatient setting,” ADVI founder and CEO Marc Samuels said in an interview with the Pink Sheet.
***end excerpt***
***
[/el-text]
View full article here
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.